For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

A woman dubbed the “injection aunt,” a figure alleged to have provided off-the-books intravenous drips and prescription drugs ...

Patient safety groups flag fatal injection risk, urging hospitals to remove tranexamic acid vials and adopt safer administration protocols.

A sweeping inspection campaign by the Jordan Food and Drug Administration (JFDA) has uncovered unapproved cosmetic injections being used inside two medical facilities in Amman, prompting immediate ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix with room-temperature stability under ...

Piperacillin and Tazobactam in the DUPLEX Drug Delivery System is one of many planned injectable drugs B. Braun will launch in the U.S. in the next several years to expand its portfolio and help meet ...

The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent ...

Celltrion to seek approval for Herzuma subcutaneous injection in first half of next year celltrion to offer cmo services converting iv drugs to rapid five‑minute sc injections ...

TB-500, and copper peptide to build muscle, rejuvenate skin, and boost longevity. But do they work and are they safe?

Cevostamab demonstrated a 38.8% overall response rate in relapsed/refractory multiple myeloma, with a median response duration of 12.3 months. BCMA-naive patients showed a higher overall response rate ...

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, recently launched Piperacillin and Tazobactam, one of the most utilized injectable antibiotics in the U.S.,1 ...